John Harrison Discusses Ibogaine Research at Provider Summit in Sayulita, Mexico:
As of April 7, 2009, the thirteenth of 30 subjects has been enrolled in the MAPS-sponsored ibogaine outcome study at the Pangea Biomedics Ibogaine Association in Playas de Tijuana, Mexico. The study is being conducted by John Harrison, PsyD Candidate at California Institute for Integral Studies.
From March 20-27, John Harrison attended an international ibogaine conference in Sayulita, Mexico. This invitation-only conference was hosted by “Awakening in The Dream House,” an ibogaine treatment clinic located in San Pancho, Mexico. The conference was held in honor of Howard Lotsof, who discovered the ‘addiction interrupting’ benefits of ibogaine more than 40 years ago. Fifty providers, clinicians, researchers, physicians, artists and journalists from around the world gathered for the conference/celebration. Among the attendees was Ken Alper, MD, who presented on the mechanism of action of ibogaine in the brain. Dr. Alper discussed addiction as pathological learning and emphasized the need for more extensive research.
John discussed MAPS ibogaine outcome study and early findings of his research. He extended invitations to several clinics and treatment providers world-wide to join with MAPS in developing further research into the psychedelic tool, ibogaine, as a treatment for addiction.